YBX1 and colorectal carcinoma: Our data showed that, similar to previous results, inhibition of YBX1 decreased the NRF2 mRNA level in CRC cells and that transfection with NRF2 plasmids rescued the NRF2 decrease caused by YBX1 knockdown (Figure 5A).